Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Eupry logo — Gain full control of your temperature compliance at all time...

Eupry

Gain full control of your temperature compliance at all times. No gaps, no mess.

Founded 2014 Denmark Denmark 66 employees Series A Total: $180.90M Biopharma, Biotechnology +4

General Information

Company Name Eupry
Founded Year 2014
Location Denmark Denmark
Founders / Decision Makers
Team member Team member
Employees 66
Industries Biopharma, Biotechnology, Health Care +3
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Eupry. To contact Eupry, visit eupry.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Eupry compare?

A PDF of Eupry and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Eupry soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Eupry

Eupry is a Danish startup, launched in 2014, that offers a digital, GxP-compliant solution for temperature and humidity compliance in the most regulated industries such as Biopharma, Biotechnology, Health Care, Information Technology, Medical Devices, and Pharmaceutical. The company's aim is to streamline and automate compliance monitoring, calibration, and mapping, eliminating the error-prone manual tasks and disjointed processes typical in these sectors. Backed by a kr170.00M Series A investment from illustrious investors including Chr. Augustinus Fabrikker, Ugly Duckling Ventures, Export and Investment Fund, and Sagitta Family Office in December 2024, Eupry reinforces its position as a game-changer in the industry. With its all-encompassing digital solution, Eupry promises to bring freedom for employees, control for quality teams, and top-tier quality standards, emphasizing that compliance should not be an arduous task.

Business keywords: Temperature Compliance, Life Science, Pharma, Biotech, Healthcare Logistics, Digitalization, Quality Standards, GxP Compliance, FDA 21 CFR Part 11, Continuous Validation, GMP, GDP, IOT, Sensor Systems

Services & Products

Temperature compliance solution including monitoring
mapping
and calibration

Target Customers

Pharmaceutical companies biotechnology firms logistics companies regulated industries

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A kr170.00M 4
Chr. Augustinus Fabrikker Ugly Duckling Ventures Export and Investment Fund
Chr. Augustinus Fabrikker, Ugly Duckling Ventures +2
20 Dec 2024
Seed Round €2.40M 2
Vaekstfonden Ugly Duckling Ventures
Vaekstfonden, Ugly Duckling Ventures
08 Aug 2022
Grant kr1.50M -
01 Jan 2018
Angel Round kr7.00M 1
Peter Sandberg
01 Nov 2017

Latest News

View All
The state of European tech in 2024, Swave Photonics secures €27M, and Brno’s dynamic startup scene — Tech
The state of European tech in 2024, Swave Photonics secures €27M, and Brno’s dynamic startup scene
Tech Jan 03, 2025

Eupry Alternatives & Competitors

View All Alternatives
Eupry vs
Chemgineering Group
Chemgineering Group Switzerland

Engineering | GMP Consulting | Qualification & Validation

157 employees
Biotechnology, Pharmaceutical
Compare Eupry vs Chemgineering Group
Eupry vs
ValGenesis
ValGenesis United States

The industry standard paperless validation software for biotech, pharma, medical device and other li...

Private Equity
625 employees
Medical Devices, Pharmaceutical
Compare Eupry vs ValGenesis
Eupry vs
Docuply
Docuply Germany

The electronic quality management system with fully integrated eTMF – for clinical biotech companies...

Seed
7 employees
Analytics, Biopharma
View all alternatives

FAQ About Eupry

Gain full control of your temperature compliance at all times. No gaps, no mess.
Eupry was founded in 2014.
Eupry is headquartered in Denmark.
Eupry operates in Biopharma, Biotechnology, Health Care, Information Technology, Medical Devices and Pharmaceutical. Its work centres on Temperature Compliance, Life Science, Pharma and Biotech. Its customers include Pharmaceutical companies, biotechnology firms and logistics companies.
Eupry has approximately 66 employees.
Eupry has completed 4 funding rounds, raising a total of $180.90M. The latest funding stage is Series A.
Eupry offers: Temperature compliance solution including monitoring, mapping, and calibration.
Top alternatives and competitors to Eupry include Chemgineering Group, ValGenesis, Docuply, Taratec Development Corporation, Vivalink. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Eupry and Chemgineering Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Eupry, https://bouncewatch.com/company/eupry, updated 25 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes